BRAF mutations occur in half of melanomas, accounting for 75.4% and 17.2% of V600E and V600K, respectively [85] PI3K-AKT signaling may also be a prerequisite for MBM, which can be stimulated by various astrocyte secretions. Here, BRAF is linked to melanoma.